Woodline Partners LP Infla Rx N.V. Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
A detailed history of Woodline Partners LP transactions in Infla Rx N.V. stock. As of the latest transaction made, Woodline Partners LP holds 751,267 shares of IFRX stock, worth $623,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
751,267
Previous 750,984
0.04%
Holding current value
$623,551
Previous $766,000
22.58%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IFRX
# of Institutions
32Shares Held
17.5MCall Options Held
32.7KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$5.38 Million0.18% of portfolio
-
683 Capital Management, LLC New York, NY2.48MShares$2.05 Million0.15% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$1.64 Million0.03% of portfolio
-
Eversept Partners, LP New York, NY1.64MShares$1.36 Million0.13% of portfolio
-
Ikarian Capital, LLC Dallas, TX705KShares$585,1580.17% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $36.7M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...